Search - tctmd.com

Displaying 161 - 180 of 279

Sort: Relevancy | Date

Presentation TCT 2015

Keynote Lecture 1: Advantages, Pitfalls, and Analysis Options for Composite Endpoints

Presenter: Ajay J. Kirtane, Roxana Mehran, Stuart J. Pocock

October 12, 2015

Presentation TCT 2015

HOT TOPIC 5: Debate Patient-Centered/-Reported Outcomes in Device Studies: How Will This Shape the Future of Clinical Studies? Con Level of Evidence Is Weak!

Presenter: Ajay J. Kirtane, Roxana Mehran, Daniel I. Simon

October 12, 2015

Presentation TCT 2015

HOT TOPIC 5: Debate Patient-Centered/-Reported Outcomes in Device Studies: How Will This Shape the Future of Clinical Studies? Pro The Patient Matters Most!

Presenter: Ajay J. Kirtane, Roxana Mehran, Suzanne V. Arnold

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: OrbusNeich Combo

Presenter: Pieter C. Smits, Philip M. Urban, Roxana Mehran

October 12, 2015

Presentation TCT 2015

Insights From BioImage: Vulnerable Plaque Is a Systemic Disease

Presenter: Gregg W. Stone, Renu Virmani, Roxana Mehran

October 12, 2015

Presentation TCT 2015

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies Focused Commentary

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, Roxana Mehran

October 12, 2015

Presentation TCT 2015

A Tribute to Liliana Grinfeld

Presenter: Dimitrios Alexopoulos, Roxana Mehran

October 12, 2015

Presentation TCT 2015

Top 10 Lessons for Complication-Free TAVR

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Philippe Généreux

October 11, 2015

Presentation TCT 2015

How to Prevent Annular Rupture, Coronary Occlusion, and Permanent Pacemakers

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Oscar A. Mendiz

October 11, 2015

Presentation TCT 2015

Late Applications in TAVR

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Antonio Enrique Dager

October 11, 2015

Presentation TCT 2015

Is Cerebral Protection Necessary?

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Alexandra J. Lansky

October 11, 2015

Presentation TCT 2015

How to Achieve 90% Success in Treating CTO Lesions

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Emmanouil S. Brilakis

October 11, 2015

Presentation TCT 2015

Routine IVUS and FFR: Is It Really Worth It?

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Fernando Cura

October 11, 2015

Presentation TCT 2015

Three to Six Months of DAPT Is My Practice Even in Very Complex Cases: Heres Why

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Fausto Feres

October 11, 2015

Presentation TCT 2015

Who Receives Bioresorbable Scaffolds in My Practice, and What Are My Tips and Tricks?

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Roberto Botelho

October 11, 2015

Presentation TCT 2015

Which Patients With Multivessel Disease and Diabetes Do I Treat With PCI, and How?

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Expedito E. Ribeiro

October 11, 2015

Presentation TCT 2015

From WOEST, DAPT, and PEGASUS to GLOBAL LEADERS and TWILIGHT: What Answers Can We Expect (and Not Expect) From GLOBAL LEADERS and TWILIGHT?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Roxana Mehran

October 11, 2015

Presentation TCT 2015

Introduction: Why Is This Issue Important? Ischemia vs Bleeding

Presenter: Regina Deible, Roxana Mehran

October 11, 2015

News Conference News TCT 2014

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

Presentation TCT 2014

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Graham A. Cassel

September 16, 2014

Advertisement

Keynote Lecture 1: Advantages, Pitfalls, and Analysis Options for Composite Endpoints

HOT TOPIC 5: Debate Patient-Centered/-Reported Outcomes in Device Studies: How Will This Shape the Future of Clinical Studies? Con Level of Evidence Is Weak!

HOT TOPIC 5: Debate Patient-Centered/-Reported Outcomes in Device Studies: How Will This Shape the Future of Clinical Studies? Pro The Patient Matters Most!

Device and Clinical Program Highlights: OrbusNeich Combo

Insights From BioImage: Vulnerable Plaque Is a Systemic Disease

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies Focused Commentary

A Tribute to Liliana Grinfeld

Top 10 Lessons for Complication-Free TAVR

How to Prevent Annular Rupture, Coronary Occlusion, and Permanent Pacemakers

Late Applications in TAVR

Is Cerebral Protection Necessary?

How to Achieve 90% Success in Treating CTO Lesions

Routine IVUS and FFR: Is It Really Worth It?

Three to Six Months of DAPT Is My Practice Even in Very Complex Cases: Heres Why

Who Receives Bioresorbable Scaffolds in My Practice, and What Are My Tips and Tricks?

Which Patients With Multivessel Disease and Diabetes Do I Treat With PCI, and How?

From WOEST, DAPT, and PEGASUS to GLOBAL LEADERS and TWILIGHT: What Answers Can We Expect (and Not Expect) From GLOBAL LEADERS and TWILIGHT?

Introduction: Why Is This Issue Important? Ischemia vs Bleeding

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content